{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:00:12Z","timestamp":1790240412938,"version":"4.1.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012276","name":"Tillotts Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Appropriate antibiotic therapy is a key determinant of outcomes in Pseudomonas aeruginosa bloodstream infection (BSI), but the impact of adequate source control on prognosis has not been well defined in large cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective multicenter study including hospitalized patients with P. aeruginosa BSI across 14 Italian hospitals between January 2021 and December 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 639 BSI episodes were analyzed. The most frequent sources were an unknown source (31.8%), central venous catheter BSI (22.5%), hospital-acquired\/ventilator-associated pneumonia (20.3%), urinary tract infections (11.4%), and intra-abdominal infections (6.9%). Source control was required in 34.0% of cases and was achieved early and adequately in 49.3% of these. The 30-day all-cause mortality rate was 23.9%. Mortality was significantly lower in patients who received early adequate source control (6.5%) compared with those without early adequate source control (23.6%) or in whom it was deemed unnecessary (28.4%) (P &amp;lt; .0001). In multivariable analysis, age, corticosteroid therapy, and septic shock were independently associated with increased mortality, whereas prior P. aeruginosa colonization, early adequate source control, and appropriate antibiotic therapy were protective. A propensity score\u2013matched analysis confirmed the association between early adequate source control and reduced 30-day mortality (adjusted hazard ratio 0.15; P = .0024).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early adequate source control is a critical determinant of survival in P. aeruginosa BSI. Outcomes are optimized by a combined approach integrating timely source control with appropriate antibiotic therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag488","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T11:40:48Z","timestamp":1787398848000},"source":"Crossref","is-referenced-by-count":0,"title":["Source Control in\n                    <i>Pseudomonas aeruginosa<\/i>\n                    Bloodstream Infections: An Overlooked Pillar in Reducing 30-Day All-Cause Mortality"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0697-3992","authenticated-orcid":false,"given":"Antonio","family":"Vena","sequence":"first","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genoa , Genoa ,","place":["Italy"]},{"name":"Clinica Malattie Infettive, AOM - IRCCS Ospedale Policlinico San Martino , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Bavastro","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genoa , Genoa ,","place":["Italy"]},{"name":"Clinica Malattie Infettive, AOM - IRCCS Ospedale Policlinico San Martino , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0297-1019","authenticated-orcid":false,"given":"Marco","family":"Muccio","sequence":"additional","affiliation":[{"name":"Clinica Malattie Infettive, AOM - IRCCS Ospedale Policlinico San Martino , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Schenone","sequence":"additional","affiliation":[{"name":"Clinica Malattie Infettive, AOM - IRCCS Ospedale Policlinico San Martino , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Corcione","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Infectious Diseases, University of Turin , Turin ,","place":["Italy"]},{"name":"Department of Infectious Diseases, Tufts University School of Medicine , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Pascale","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, IRCCS-Sant\u2019 Orsola Polyclinic , Bologna ,","place":["Italy"]},{"name":"Department of Medical and Surgical Sciences, University of Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele Roberto","family":"Giacobbe","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genoa , Genoa ,","place":["Italy"]},{"name":"Clinica Malattie Infettive, AOM - IRCCS Ospedale Policlinico San Martino , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Mornese Pinna","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Infectious Diseases, University of Turin , Turin ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Pari","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Infectious Diseases, University of Turin , Turin ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Giovannenze","sequence":"additional","affiliation":[{"name":"Department of Laboratory and Infectious Sciences, IRCCS A. Gemelli University Polyclinic Foundation , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7988-5419","authenticated-orcid":false,"given":"Nicholas","family":"Geremia","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Department of Clinical Medicine, Dell\u2019Angelo Hospital , Venice ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Mikulska","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genoa , Genoa ,","place":["Italy"]},{"name":"Clinica Malattie Infettive, AOM - IRCCS Ospedale Policlinico San Martino , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Taddei","sequence":"additional","affiliation":[{"name":"Department of Laboratory and Infectious Sciences, IRCCS A. Gemelli University Polyclinic Foundation , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Sangiorgi","sequence":"additional","affiliation":[{"name":"Department of Security and Bioethics-Infectious Diseases Section, Catholic University of the Sacred Heart , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide Fiore","family":"Bavaro","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University , Milan ,","place":["Italy"]},{"name":"Infectious Disease Unit, IRCCS Humanitas Research Hospital , Rozzano, Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2911-2255","authenticated-orcid":false,"given":"Vincenzo","family":"Scaglione","sequence":"additional","affiliation":[{"name":"Infectious and Tropical Diseases Unit, Padua University Hospital , Padua ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Sisto","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genoa , Genoa ,","place":["Italy"]},{"name":"Clinica Malattie Infettive, AOM - IRCCS Ospedale Policlinico San Martino , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6622-6358","authenticated-orcid":false,"given":"Lucia","family":"Taramasso","sequence":"additional","affiliation":[{"name":"Clinica Malattie Infettive, AOM - IRCCS Ospedale Policlinico San Martino , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7097-0710","authenticated-orcid":false,"given":"Veronica","family":"Vassia","sequence":"additional","affiliation":[{"name":"Infectious and Tropical Disease Unit, Mauriziano Umberto I Hospital , Turin ,","place":["Italy"]},{"name":"Infectious and Tropical Disease Unit, Civile Hospital , Ivrea ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bartoletti","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University , Milan ,","place":["Italy"]},{"name":"Infectious Disease Unit, IRCCS Humanitas Research Hospital , Rozzano, Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Giuseppe","family":"De Rosa","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Infectious Diseases, University of Turin , Turin ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Giannella","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, IRCCS-Sant\u2019 Orsola Polyclinic , Bologna ,","place":["Italy"]},{"name":"Department of Medical and Surgical Sciences, University of Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1264-0008","authenticated-orcid":false,"given":"Pierluigi","family":"Viale","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, IRCCS-Sant\u2019 Orsola Polyclinic , Bologna ,","place":["Italy"]},{"name":"Department of Medical and Surgical Sciences, University of Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), University of Genoa , Genoa ,","place":["Italy"]},{"name":"Clinica Malattie Infettive, AOM - IRCCS Ospedale Policlinico San Martino , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"SITA GIOVANI (Young Investigators Group of the Societ\u00e0 Italiana Terapia Antinfettiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Accurso","family":"Giuseppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bavaro Davide","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiappetta","family":"Stefania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faliero","family":"Domenico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumarola","family":"Benedetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geremia","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovannenze","family":"Francesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maccaro","family":"Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marino","family":"Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merli","family":"Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pagani","family":"Gabriele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sardanelli","family":"Alessia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scaglione","family":"Vincenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tontodonati","family":"Monica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassia","family":"Veronica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"2026092404084998600_ofag488-B1","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"2026092404084998600_ofag488-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2026092404084998600_ofag488-B3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamasurg.2022.2761","article-title":"Association between time to source control in sepsis and 90-day mortality","volume":"157","author":"Reitz","year":"2022","journal-title":"JAMA Surg"},{"key":"2026092404084998600_ofag488-B4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2165\/00003495-199753040-00004","article-title":"A practical guide to the management of complicated urinary tract infection","volume":"53","author":"Nicolle","year":"1997","journal-title":"Drugs"},{"key":"2026092404084998600_ofag488-B5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10096-023-04557-1","article-title":"Predictors of mortality of Staphylococcus aureus bacteremia among patients hospitalized in a Swiss University Hospital and the role of early source control; a retrospective cohort study","volume":"42","author":"Papadimitriou-Olivgeris","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026092404084998600_ofag488-B6","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/cid\/ciae168","article-title":"Predictors of mortality of streptococcal bacteremia and the role of infectious diseases consultation: a retrospective cohort study","volume":"78","author":"Fourre","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026092404084998600_ofag488-B7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.cmi.2016.01.016","article-title":"Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae","volume":"22","author":"Falcone","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2026092404084998600_ofag488-B8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13054-020-2793-y","article-title":"Factors associated with the development of septic shock in patients with candidemia: a post hoc analysis from two prospective cohorts","volume":"24","author":"Bassetti","year":"2020","journal-title":"Crit Care"},{"key":"2026092404084998600_ofag488-B9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","journal-title":"Lancet"},{"key":"2026092404084998600_ofag488-B10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2026092404084998600_ofag488-B11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.7326\/M23-2309","article-title":"Assessing clinician utilization of next-generation antibiotics against resistant Gram-negative infections in U.S. hospitals: a retrospective cohort study","volume":"177","author":"Strich","year":"2024","journal-title":"Ann Intern Med"},{"key":"2026092404084998600_ofag488-B12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/QCO.0000000000000505","article-title":"Rational approach in the management of Pseudomonas aeruginosa infections","volume":"31","author":"Bassetti","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"2026092404084998600_ofag488-B13","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.2147\/IDR.S268744","article-title":"Risk factors for mortality of inpatients with Pseudomonas aeruginosa bacteremia in China: impact of resistance profile in the mortality","volume":"13","author":"Zhang","year":"2020","journal-title":"Infect Drug Resist"},{"key":"2026092404084998600_ofag488-B14","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/cid\/cis1006","article-title":"Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection","volume":"56","author":"Ammerlaan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2026092404084998600_ofag488-B15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/AAC.00901-06","article-title":"Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia","volume":"51","author":"Osih","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2026092404084998600_ofag488-B16","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/jac\/dkae296","article-title":"Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort study","volume":"79","author":"Vena","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"2026092404084998600_ofag488-B17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/377200","article-title":"Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome","volume":"37","author":"Kang","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2026092404084998600_ofag488-B18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.diagmicrobio.2011.05.010","article-title":"Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapy","volume":"71","author":"Schechner","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026092404084998600_ofag488-B19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s15010-024-02326-6","article-title":"Predictors of mortality of Pseudomonas aeruginosa bacteraemia and the role of infectious diseases consultation and source control; a retrospective cohort study","volume":"53","author":"Papadimitriou-Olivgeris","year":"2025","journal-title":"Infection"},{"key":"2026092404084998600_ofag488-B20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1186\/s12879-021-06372-5","article-title":"The impact of infectious diseases consultation on the management and outcomes of Pseudomonas aeruginosa bacteraemia in adults: a retrospective cohort study","volume":"21","author":"Chiong","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2026092404084998600_ofag488-B21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2026092404084998600_ofag488-B22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/cid\/ciw504","article-title":"Executive summary: management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026092404084998600_ofag488-B23","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"2026092404084998600_ofag488-B24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"2026092404084998600_ofag488-B25","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2026092404084998600_ofag488-B26"},{"key":"2026092404084998600_ofag488-B27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.CCM.0000194725.48928.3A","article-title":"Sepsis in European intensive care units: results of the SOAP study","volume":"34","author":"Vincent","year":"2006","journal-title":"Crit Care Med"},{"key":"2026092404084998600_ofag488-B28","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00078-18","article-title":"Optimization and evaluation of piperacillin-tobramycin combination dosage regimens against Pseudomonas aeruginosa for patients with altered pharmacokinetics via the hollow-fiber infection model and mechanism-based modeling","volume":"62","author":"Yadav","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2026092404084998600_ofag488-B29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106512","article-title":"Beta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to Pseudomonas aeruginosa: a meta-analysis","volume":"59","author":"Onorato","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"2026092404084998600_ofag488-B30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European Society of Intensive Care Medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2026092404084998600_ofag488-B31","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026092404084998600_ofag488-B32","doi-asserted-by":"crossref","first-page":"105847","DOI":"10.1016\/j.ijantimicag.2019.11.004","article-title":"Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study","volume":"55","author":"Babich","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"2026092404084998600_ofag488-B33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282276","article-title":"Clinical predictors of mortality in patients with pseudomonas aeruginosa infection","volume":"18","author":"Frem","year":"2023","journal-title":"PLoS One"},{"key":"2026092404084998600_ofag488-B34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jgar.2024.03.018","article-title":"Risk factors and mortality of carbapenem-resistant Pseudomonas aeruginosa bloodstream infection in haematology department: a 10-year retrospective study","volume":"37","author":"Yuan","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"2026092404084998600_ofag488-B35","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/jac\/dkz491","article-title":"An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia","volume":"75","author":"Cardozo","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2026092404084998600_ofag488-B36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40121-020-00281-x","article-title":"Efficacy of a \u201cchecklist\u201d intervention bundle on the clinical outcome of patients with Candida bloodstream infections: a quasi-experimental pre-post study","volume":"9","author":"Vena","year":"2020","journal-title":"Infect Dis Ther"},{"key":"2026092404084998600_ofag488-B37","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/cid\/cit499","article-title":"Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia","volume":"57","author":"Lopez-Cortes","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2026092404084998600_ofag488-B38","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac456","article-title":"Infectious disease consults of Pseudomonas aeruginosa bloodstream infection and impact on health outcomes","volume":"9","author":"Ramanathan","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2026092404084998600_ofag488-B39","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1128\/AAC.00750-12","article-title":"Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia","volume":"56","author":"Morata","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2026092404084998600_ofag488-B40","article-title":"Combined resistance to ceftolozane-tazobactam and ceftazidime-avibactam in extensively drug-resistant (XDR) and multidrug-resistant (MDR) Pseudomonas aeruginosa: resistance predictors and impact on clinical outcomes besides implications for antimicrobial stewardship programs","volume":"10","author":"Meschiari","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"2026092404084998600_ofag488-B41","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.burns.2010.05.009","article-title":"Pseudomonas aeruginosa bacteraemia in burns patients: risk factors and outcomes","volume":"36","author":"Mahar","year":"2010","journal-title":"Burns"},{"key":"2026092404084998600_ofag488-B42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhin.2024.04.007","article-title":"Short versus prolonged duration of therapy for Pseudomonas aeruginosa bacteraemia: a systematic review and meta-analysis","volume":"148","author":"Ranganath","year":"2024","journal-title":"J Hosp Infect"},{"key":"2026092404084998600_ofag488-B43","doi-asserted-by":"crossref","first-page":"e4599","DOI":"10.1093\/cid\/ciaa1306","article-title":"Modifiable risk factors for the emergence of ceftolozane-tazobactam resistance","volume":"73","author":"Tamma","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/9\/ofag488\/71372474\/ofag488.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/9\/ofag488\/71372474\/ofag488.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:09:00Z","timestamp":1790237340000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag488\/8833365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag488","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9,1]]},"article-number":"ofag488"}}